)
Edge31 Oct 2025
Rolls-Royce: Full Thrust Ahead
From century-old crafted perfection to pandemic shock and reset, Rolls-Royce's story is shaped by heritage, turbulence, and a disciplined climb back.
Olympus Corporation (7733) investor relations material
Olympus Corporation Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary7 Nov, 2025
Executive summary
Medium-term plan targets gradual revenue growth of 3%, 4%, and 5% over three years, with 2Q FY2026 results largely in line with forecasts and no change to full-year guidance as further recovery is expected in the second half.
Focus on innovation-driven growth, new product launches, and external partnerships, including the OLYSENSE intelligent endoscopy ecosystem and Swan EndoSurgical joint venture.
Restructuring includes a reduction of approximately 2,000 positions and a shift to a division-led operating model to enhance efficiency and accountability.
Achieved strong growth in emerging markets by expanding market reach and access capabilities, while local manufacturing in China is progressing well.
The Orthopedic Business was classified as a discontinued operation from the six months ended September 30, 2024.
Financial highlights
2Q FY2026 revenue: ¥247.8B, up 4% year-over-year after FX adjustment; 6-month revenue: ¥454.4B, down 2% year-over-year after FX adjustment.
Adjusted operating profit: ¥37.4B for 2Q (15.1% margin), down 9% year-over-year; 6-month adjusted operating profit: ¥50.6B, down 32% year-over-year.
Margin improvement targeted at 100 basis points per year, aiming for 19% adjusted operating profit by FY2026.
One-time restructuring costs of JPY 30 billion over two years, with JPY 12 billion included in current forecasts.
Profit attributable to owners of parent for 2Q: ¥20.2B, up 125% sequentially from 1Q; 6-month profit: ¥29.2B, down 40.4% year-over-year.
Outlook and guidance
FY2026 revenue forecast: ¥998.0B, flat year-over-year, with 3% growth after FX adjustment; adjusted operating profit forecast: ¥157.0B (15.7% margin), down 9% year-over-year after FX adjustment.
Profit attributable to owners of parent forecast: ¥94.0B; EPS: ¥85; annual dividend forecast: ¥30/share, up ¥10/share; ¥50B share buyback planned.
No inorganic growth (M&A, JVs, distribution deals) included in current forecasts; such opportunities would be incremental.
No changes to previously announced forecasts; forward-looking statements are subject to risks from global economic and trade policy uncertainties.
Key drivers of profit decline and recovery plan
Swan EndoSurgical JV: strategic rationale and outlook
Capital allocation strategy given profit decline
Endoluminal robotics: Olympus's leadership path
GI MDA scopes: Regain market share strategy
Org reform: Sales opportunities risk?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Olympus Corporation earnings date
Q3 202613 Feb, 2026
Next Olympus Corporation earnings date
Q3 202613 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Olympus Corporation, established on October 12, 1919, is a global technology leader specializing in the design and delivery of innovative solutions for medical and surgical procedures, among other core areas. The company's primary focus lies in the manufacture and sales of precision machinery and instruments, particularly in the field of medical endoscopes, ultrasound, electrocautery, endotherapy, and cleaning and disinfection equipment. The company is headquartered in Tokyo, Japan, and its shares are listed on the Tokyo Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage